Dr. Janet Woodcock, Director of FDA's Center for Drug Evaluation and Research (CDER) presented the opening keynote at NORD's Rare Diseases and Orphan Products Breakthrough Summit in Washington, DC on October 21.
Her remarks focused on how the patient advocacy community can most effectively accelerate therapy development along the drug development…
Added by Ryan Fischer on October 23, 2014 at 9:30am — No Comments
© 2021 Created by PPMD.
Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service